Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia

https://doi.org/10.1016/0278-5846(94)90102-3Get rights and content

Abstract

  • 1.

    1. Several clinical and post-mortem tissue findings have suggested a role for excitatory amino acid neuronal systems in the pathophysiology of schizophrenia.

  • 2.

    2. These include the ability of NMDA antagonists, phencyclidine and ketamine, to cause both negative and positive symptoms in healthy subjects, and abnormalities in the densities of some types of excitatory amino acid receptors in the postmortem tissue of schizophrenic brains.

  • 3.

    3. The present review describes recent basic findings that have examined the involvement of excitatory amino acids in the mechanism of action of antipsychotic drugs. These include studies on the functional links between glutamatergic and dopaminergic systems, effect of acute and chronic antipsychotic drug treatment on excitatory amino acid function, and stress-induced activation of excitatory amino acid release, in particular in the prefrontal cortex.

References (55)

  • A. Imperato et al.

    NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudate nucleuse

    Eur. J. Pharmacol.

    (1990)
  • K.A. Keefe et al.

    Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic imput

    Neurosci.

    (1992)
  • J.A. Kemp

    Non-competitive antagonists of excitatory amino acid receptors

    Trends Neurosci.

    (1987)
  • J.S. Kim et al.

    Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

    Neurosci. Lett.

    (1980)
  • J. Kornhuber et al.

    Presynaptic dopaminergic modulation of cortical input to the striatum

    Life Sci.

    (1986)
  • M. Lauritzen et al.

    Quisqualate, kainate and NMDA can initiate spreading Depression in the turtle cerebellum

    Brain Res.

    (1988)
  • V. Leviel et al.

    The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory funciton

    Neurosci.

    (1990)
  • B. Moghaddam et al.

    Effect of l-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies

    Brain Res.

    (1990)
  • B. Moghaddam et al.

    Do endogenous excitatory amino acids influence striatal dopamine release?

    Brain Res.

    (1991)
  • T. Nishikawa et al.

    Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

    Neurosci. Lett.

    (1983)
  • T.S. Rao et al.

    Clozapine attenuates N-methyl-d-aspartate receptor complex- mediated responses in vivo: Tentative evidence for a functional modulation by a noradrenergic mechanism

    Neuropharmacol.

    (1991)
  • H. Wachtel et al.

    Glutamate: A new target in schizophrenia?

    Trends Pharmacol. Sci.

    (1990)
  • D.R. Weinberger

    Schizophrenia and the frontal lobe

    Trends in Neurosci.

    (1988)
  • L. Barbeito et al.

    Glutamate receptors of a quisqualate-kainate subtype are involved in the presynaptic regulation of dopamine release in the cat caudate nucleusin vivo

    Eur. J. Neurosci.

    (1990)
  • H. Benveniste et al.

    Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis

    J. Neurochem.

    (1984)
  • A. Björklund et al.

    Dopamine-containing systems in the CNS.

  • B.S. Bunney et al.

    Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

    Life Sci.

    (1978)
  • Cited by (0)

    View full text